Related Articles
Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer
FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics
Activated Akt signaling pathway in invasive ductal carcinoma of the breast: Correlation with HER2 overexpression
Association of osteopontin and cyclooxygenase‑2 expression with breast cancer subtypes and their use as potential biomarkers
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer